Capital Performance
Armistice Capital Performance in Healthcare Sector Shows Strategic Focus on Medical Innovation
Investment activities and regulatory filings reveal Armistice Capital’s targeted approach to healthcare sector investments, with significant positions established across ophthalmology, women’s health technology, and biotechnology ventures. The firm’s portfolio selections demonstrate a calculated strategy focused on advancing medical solutions and therapeutic developments. Recent developments in the ophthalmic sector underscore this investment approach, with third-quarter 2023 […]